FLGC | Jotup

Lifeist Terminates Agreement for Sale of Australian Vapes

Retrieved on:

Wednesday, October 25, 2023

Science, News, Vaporizer, FLGC, Growth, SPA

TORONTO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness announces the termination of the share purchase agreement (the "SPA") entered into on September 17, 2023 with Flora Growth Corp. (NASDAQ: FLGC) (“Flora”) to divest and sell Australian Vaporizers Pty Limited (“Australian Vapes”), its wholly owned Australian subsidiary, to Flora.

Key Points:

TORONTO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness announces the termination of the share purchase agreement (the "SPA") entered into on September 17, 2023 with Flora Growth Corp. (NASDAQ: FLGC) (“Flora”) to divest and sell Australian Vaporizers Pty Limited (“Australian Vapes”), its wholly owned Australian subsidiary, to Flora.
The transaction and its details were previously disclosed in a news release dated September 18, 2023, a copy of which can be found on SEDAR+ under the Company’s profile.
“In parallel we will continue to operate Australian Vaporizers and accelerate plans to increase its growth."
Lifeist remains dedicated to its mission of delivering wellness solutions and will continue to pursue opportunities that drive its long-term vision forward.

Lifeist Announces Sale of Non-core Subsidiary Australian Vapes

Retrieved on:

Monday, September 18, 2023

Treasury, FLGC, Sale, Science, VWAP, Transaction, SPA, Growth

"Australian Vapes is a legacy business within Lifeist and its sale represents another step of our transformation into a portfolio of wellness focused products and ventures,” said Meni Morim, CEO of Lifeist Wellness.

Key Points:

"Australian Vapes is a legacy business within Lifeist and its sale represents another step of our transformation into a portfolio of wellness focused products and ventures,” said Meni Morim, CEO of Lifeist Wellness.
“The decision to divest Australian Vapes aligns both strategically and financially with our long-term business plans.
Further, Australian Vapes is accretive to Flora's existing operations and we expect it to accelerate its growth under Flora’s complementary business model.
Kronos Capital Partners is acting as financial advisor to Lifeist.

Flora Growth Corp. to Effect Reverse Stock Split

Retrieved on:

Wednesday, June 7, 2023

Finance, Cannabis, Specialty, Professional Services, Alternative Medicine, Health, Retail, Supply Chain Management, Natural Resources, ISIN, FLGC, CUSIP, Reverse stock split, Security (finance)

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora” or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, announces that it will effect a reverse stock split, which shall become effective on June 9, 2023 at a ratio of 1-for-20 (the “Reverse Stock Split”).

Key Points:

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora” or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, announces that it will effect a reverse stock split, which shall become effective on June 9, 2023 at a ratio of 1-for-20 (the “Reverse Stock Split”).
As a result of the Reverse Stock Split, every 20 common shares issued and outstanding will be automatically reclassified into one new common share.
The Reverse Stock Split does not affect any shareholder’s ownership percentage of the common shares or modify any voting rights or other terms of the common shares.
No fractional common shares will be issued as a result of the Reverse Stock Split.

Flora Growth Corp. Announces Change to Location of Annual and Special Meeting

Retrieved on:

Wednesday, May 24, 2023

Alternative Medicine, Cannabis, Retail, Health, Agriculture, Natural Resources, Specialty, SEDAR, FLGC, Proxy, Eastern Time Zone, Auction

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora” or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, announces a change to the location of its annual and special meeting of shareholders to be held on June 6, 2023 at 9:00am Eastern Time (the “Meeting”).

Key Points:

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora” or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, announces a change to the location of its annual and special meeting of shareholders to be held on June 6, 2023 at 9:00am Eastern Time (the “Meeting”).
The new location for the Meeting will be at the offices of Greenberg Traurig, P.A.
at 401 East Las Olas Boulevard Suite 2000, Fort Lauderdale, Florida 33301.
There is no change in the previously announced date or time of the Meeting.

Flora Growth Reports First Quarter 2023 Financial Results

Retrieved on:

Monday, May 15, 2023

Alternative Medicine, Cannabis, Retail, Health, Agriculture, Natural Resources, Specialty, Delays, FLGC, Rakin Fetuga, EBITDA, Acquisition, Commercial, House, Drug, Pharmaceutical industry, Wholesaling

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, reported today its financial and operating results for the quarter ended March 31, 2023.

Key Points:

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, reported today its financial and operating results for the quarter ended March 31, 2023.
“As I take the reins of the organization, I am pleased to share the results of the first quarter of 2023, which included increased revenue generation for the Company,” said Hussein Rakine, newly appointed CEO of Flora.
“The first quarter was focused on strengthening our operational performance, focusing on financial discipline, and optimizing the integrations of all our M&A transactions.
Our House of Brands continued to be the primary revenue-generating pillar, posting sequential growth and steady margins.

Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors

Retrieved on:

Tuesday, April 18, 2023

Agriculture, Natural Resources, Cannabis, Other Natural Resources, The Conference Board, FLGC, MBA, Liberty University, Nova Southeastern University, Flora, Growth, Management

To fill the vacancies created by Mr. Merchan’s resignation, the Board has appointed JustCBD founder, Hussein Rakine, as CEO and member of the board of directors.

Key Points:

To fill the vacancies created by Mr. Merchan’s resignation, the Board has appointed JustCBD founder, Hussein Rakine, as CEO and member of the board of directors.
Of the appointment, former-Chairman and CEO, Luis Merchan said, “At Flora we have consistently placed human capital as a critical part of our M&A strategy.
I believe Hussein’s appointment will ensure continued growth within the Company.”
“I am enthusiastic about collaborating with our board of directors, executive team, and all stakeholders to bring Flora's business plan to fruition,” said Hussein Rakine.
Hussein Rakine founded Just Brands LLC in 2017 and served as its CEO until it was acquired by Flora in February 2022.

Flora Growth Receives CGMP Certification of Compound Formulation Lab; Launches Prescription Cannabis Medicines in Colombia

Retrieved on:

Tuesday, April 4, 2023

Flora Lab 4 specializes in manufacturing compound formulations utilizing cannabis derivatives and traditional master formulas.

Key Points:

Flora Lab 4 specializes in manufacturing compound formulations utilizing cannabis derivatives and traditional master formulas.
Flora Lab 4 will now begin offering its cannabis formulations as well as design, development and manufacturing services for third parties.
“We are very pleased to have received CGMP certification and to bring effective medicinal cannabis treatments to patients in Colombia.
Flora is committed to creating sustainable growth in its Pharmaceutical division by utilizing high-quality raw materials sourced from its cannabis cultivation and processing operations in Colombia.

Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-Year

Retrieved on:

Friday, March 31, 2023

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, reported today its financial and operating results for the fiscal year ended December 31, 2022.

Key Points:

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, reported today its financial and operating results for the fiscal year ended December 31, 2022.
“In 2022, we not only met our revenue guidance but reported both quarterly and annual record revenue.
Additionally, in Q4 2022, revenue was $11.5 million, a 7% sequential increase from Q3 2022, driven primarily by organic growth.
A reconciliation of U.S. GAAP to non-U.S. GAAP financial measures has been provided in the section titled “About Non-GAAP Financial Measures”.

Flora Growth to Announce 2022 Year End Results April 3, 2023, at 8:00 a.m. ET

Retrieved on:

Tuesday, March 21, 2023

Cannabis, Supply Chain Management, Natural Resources, Retail, Specialty, Webcast, FLGC, Medication, Commercial, House, Q&A, Wholesaling

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, will host its 2022 year end earnings call via webcast on Monday, April 3, 2023 at 8:00 a.m.

Key Points:

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, will host its 2022 year end earnings call via webcast on Monday, April 3, 2023 at 8:00 a.m.
During the webcast, Flora management will deliver financial and operational results for the year ended December 31, 2022, and provide updates on Flora’s House of Brands, Commercial & Wholesale operations and Pharmaceutical division strategies.
Following the webcast, Flora management will open the call to analysts in a Q&A format.
The live webcast will be available online and a link to join will be provided upon registration.

Flora Growth Begins Product Sales in Juan Valdez, Colombia’s Largest Coffeehouse Chain

Retrieved on:

Tuesday, February 21, 2023

Cannabis, Retail, Other Natural Resources, Other Retail, Natural Resources, Specialty, Food, Beverage, Farmer, Partnership, FLGC, House, Sale, Coffee, Via, Drug, Ypadu, Juan Valdez

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, announced today it has successfully begun distribution of its House of Brands product offering through the Juan Valdez coffeehouse chain.

Key Points:

Flora Growth Corp. (NASDAQ: FLGC ) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, announced today it has successfully begun distribution of its House of Brands product offering through the Juan Valdez coffeehouse chain.
The agreement was signed with Procafecol S.A., the parent company of Juan Valdez, the world's most well-known Colombian coffee brand and the largest chain of coffeehouses in Colombia.
Flora’s natural fruit juice brand, Mambe, is the initial offering in-store and can now be found in 286 Juan Valdez locations.
“We are very proud to partner with the Juan Valdez brand to bring Flora products to market in the largest coffeehouse chain in Colombia,” said Luis Merchan, Chairman and CEO of Flora.